Posted in | News

New Detectors for Field-Flow Fractionation

Postnova Analytics, the leading international supplier of Field-Flow Fractionation (FFF) systems, has announced that it will be launching a series of exciting new products at the forthcoming Analytica 2016 in Munich, Germany.

Visitors to Analytica Hall 1 Booth 329 will be able to see the official launch of Postnova’s innovative, new Size Exclusion Chromatography (SEC) option, together with its new powerful NovaSEC software.

The new Postnova SC2000 Modular SEC option offers unrivalled flexibility in Advanced SEC/GPC analysis. It is the first truly modular multi-detector SEC system available allowing flexible access to a wide range of applications.

The economical, flexible and scalable SC2000 is an exciting option for the Postnova FFF Characterization Platform. Offering both FFF and SEC capabilities the 2000-Series Characterization Platform will uniquely provide laboratories for the first time a single platform able to separate both particles and molecules.

Furthermore, at Analytica 2016, Postnova will additionally launch the PN3310 Viscometer Detector designed to perfectly match the high performance 21-angle Postnova MALS detector to offer users a high performance Triple Detection System for both SEC and FFF.

For further information please visit or contact Postnova Analytics on +44-1885-475007 / [email protected].


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Postnova Analytics. (2019, February 08). New Detectors for Field-Flow Fractionation. AZoM. Retrieved on April 14, 2024 from

  • MLA

    Postnova Analytics. "New Detectors for Field-Flow Fractionation". AZoM. 14 April 2024. <>.

  • Chicago

    Postnova Analytics. "New Detectors for Field-Flow Fractionation". AZoM. (accessed April 14, 2024).

  • Harvard

    Postnova Analytics. 2019. New Detectors for Field-Flow Fractionation. AZoM, viewed 14 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.